Overview
🌐 Website: icadmed.com
💲 Revenue:
📍 Address: United States
👥 Employees:
🗓️ Established: 1984
📅 Published: December 20, 2014
✏️ Last updated: July 31, 2022
iCAD
AskAI Summary of iCAD
Generated using ISVWorld's AskAI proprietary software industry model.
📝 AskAI Recap: iCAD, Inc. is a global leader in developing and selling AI-powered software solutions for breast cancer detection, density assessment, and risk evaluation. Their flagship product suite, ProFound Breast Health Suite, provides FDA-cleared, clinically proven AI software that integrates into radiologist workflows to improve diagnostic accuracy and patient outcomes worldwide.
💬 Inclusion Rationale: Based on the extensive page content, iCAD clearly develops and sells proprietary AI-driven software products specifically for cancer detection and risk assessment. Their products are FDA-cleared and marketed as standalone AI-powered software solutions used in medical imaging for breast cancer. This meets the ISV criteria as they both develop and sell software products (including SaaS) rather than just delivering custom software or services.
Contacts
Access available business contacts and professional information associated with iCAD through the interactive ISVWorld profile.
Similar Companies
Explore companies similar to iCAD based on software focus, industries, technologies, and market positioning.
Classifications
Company Tags
External Profiles
Scores
Company News
View the latest company news, product announcements, partnerships, and business developments related to iCAD.
Relevant Industry News
Explore market and industry news relevant to iCAD and its software categories.
Funding
Review available funding rounds, investors, acquisitions, and financing activity associated with iCAD.
